Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Apr;76(4):959-974.
doi: 10.1016/j.jhep.2021.12.022. Epub 2021 Dec 30.

Baveno VII - Renewing consensus in portal hypertension

Collaborators, Affiliations
Review

Baveno VII - Renewing consensus in portal hypertension

Roberto de Franchis et al. J Hepatol. 2022 Apr.

Erratum in

Abstract

To expand on the work of previous meetings, a virtual Baveno VII workshop was organised for October 2021. Among patients with compensated cirrhosis or compensated advanced chronic liver disease (cACLD - defined at the Baveno VI conference), the presence or absence of clinically significant portal hypertension (CSPH) is associated with differing outcomes, including risk of death, and different diagnostic and therapeutic needs. Accordingly, the Baveno VII workshop was entitled "Personalized Care for Portal Hypertension". The main fields of discussion were the relevance and indications for measuring the hepatic venous pressure gradient as a gold standard, the use of non-invasive tools for the diagnosis of cACLD and CSPH, the impact of aetiological and non-aetiological therapies on the course of cirrhosis, the prevention of the first episode of decompensation, the management of an acute bleeding episode, the prevention of further decompensation, as well as the diagnosis and management of splanchnic vein thrombosis and other vascular disorders of the liver. For each of these 9 topics, a thorough review of the medical literature was performed, and a series of consensus statements/recommendations were discussed and agreed upon. A summary of the most important conclusions/recommendations derived from the workshop is reported here. The statements are classified as unchanged, changed, and new in relation to Baveno VI.

Keywords: Cirrhosis; decompensation; diagnosis; recommendations; treatment.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest None relating to this manuscript. JB has been a consultant for Zydus, Surrozen and Actelion. TR is a consultant for and/or receives research support from Abbvie, Bayer, Boehringer-Ingelheim, Gilead, Intercept, MSD, Philips, Pliant Pharmaceuticals, Roche, and Siemens. RdF, CR and GGT have no disclosures to report. Please refer to the accompanying ICMJE disclosure forms for further details.

Figures

Fig. 1.
Fig. 1.. Algorithm for the non-invasive determination of cACLD and CSPH.
ALD, alcohol-related liver disease; cACLD, compensated advanced chronic liver disease; CSPH, clinically significant portal hypertension; NASH, non-alcoholic steatohepatitis.

Comment in

Similar articles

Cited by

References

    1. Burroughs AK, editor. Methodology and review of clinical trials in portal hypertension. Amsterdam, New York, Oxford: Excerpta Medical Congress Service N◦; 763; 1987.
    1. de Franchis R, Pascal JP, Ancona E, Burroughs AK, Henderson JM, Fleig W, et al. Definitions, methodology and therapeutic strategies in portal hypertension. A consensus development workshop. J Hepatol 1992;15:256–261. - PubMed
    1. de Franchis R Developing consensus in portal hypertension. J Hepatol 1996;25:390–394. - PubMed
    1. de Franchis R, editor. Portal Hypertension II. Proceedings of the second Baveno international consensus workshop on definitions, methodology and therapeutic strategies. Oxford: Blackwell Science; 1996.
    1. Spina GP, Arcidiacono R, Bosch J, Pagliaro L, Burroughs AK, Santambrogio R, et al. Gastric endoscopic features in portal hypertension: final report of a consensus conference. J Hepatol 1994;21:461–467. - PubMed

Publication types

MeSH terms